United States
Germany
Japan
United Kingdom
China
CNY 1,999.00
CNY 2,700.00
现货
CDH2 (N Cadherin) mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | FC, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
Antibodies
CD4 mouse monoclonal antibody, clone OTI5D9 (formerly 5D9)
| Applications | IHC, WB |
| Reactivities | Human, Monkey |
CNY 1,999.00
CNY 2,700.00
现货
PIK3CG mouse monoclonal antibody,clone OTI6H5
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
ENPEP mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse |
CDH2 (N Cadherin) mouse monoclonal antibody, clone OTI2G7 (formerly 2G7)
| Applications | FC, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
Beta-catenin mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
CNY 1,999.00
CNY 2,700.00
现货
PIK3CG mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
CNY 800.00
现货
PIK3CG mouse monoclonal antibody,clone OTI6H5
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
ENPEP mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey, Mouse |
CD4 mouse monoclonal antibody, clone OTI5D9 (formerly 5D9)
| Applications | IHC, WB |
| Reactivities | Human, Monkey |
CNY 800.00
现货
PIK3CG mouse monoclonal antibody, clone OTI6C6 (formerly 6C6)
| Applications | IHC, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
Beta-catenin mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
clear Category
-
Antibodies
- Primary Antibodies
优化搜索结果
Target Symbol
Knockout (KO) Validation
Pathways
- Colorectal cancer (6)
- Endometrial cancer (6)
- Focal adhesion (6)
- Leukocyte transendothelial migration (6)
- Pathways in cancer (6)
- Prostate cancer (6)
- T cell receptor signaling pathway (6)
- Acute myeloid leukemia (4)
- Apoptosis (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- B cell receptor signaling pathway (4)
- Cell adhesion molecules (CAMs) (4)
- Chemokine signaling pathway (4)
- Chronic myeloid leukemia (4)
- ErbB signaling pathway (4)
- Fc epsilon RI signaling pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Glioma (4)
- Inositol phosphate metabolism (4)
- Insulin signaling pathway (4)
- Jak-STAT signaling pathway (4)
- Melanoma (4)
- Natural killer cell mediated cytotoxicity (4)
- Neurotrophin signaling pathway (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Phosphatidylinositol signaling system (4)
- Progesterone-mediated oocyte maturation (4)
- Regulation of actin cytoskeleton (4)
- Renal cell carcinoma (4)
- Small cell lung cancer (4)
- Toll-like receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- VEGF signaling pathway (4)
- mTOR signaling pathway (4)
- Adherens junction (2)
- Antigen processing and presentation (2)
- Basal cell carcinoma (2)
- Hematopoietic cell lineage (2)
- Melanogenesis (2)
- Pathogenic Escherichia coli infection (2)
- Primary immunodeficiency (2)
- Renin-angiotensin system (2)
- Thyroid cancer (2)
- Tight junction (2)
- Wnt signaling pathway (2)
